New Research Poster Presentation 6.43: Quality of Life Improvement in Adolescent Schizophrenia and Pediatric Bipolar Disorder Following Treatment with Aripiprazole

Saturday, October 31, 2009 9:00 AM

Jean Endicott, Ph.D., Clinical Psychology, Columbia University, New York, NY

Chien-Feng Chen, Ph.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Richard Whitehead, B.S., Medical Affairs, Otsuka America Pharmaceutical, Inc., Rockville, MD

Edward Kim, M.D., M.B.A., Health Economics and Outcomes Research, Bristol-Myers Squibb Company, Plainsboro, NJ

Margaretta Nyilas, M.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

William Carson, M.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Taro Iwamoto, Ph.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Quynh-Van Tran, PharmD, Medical Affairs, Otsuka America Pharmaceutical, Inc., Rockville, MD

Andrei Pikalov, M.D., Ph.D., Otsuka America Pharmaceutical, Inc., Rockville, MD

Suja Mathew, B.S., Otsuka America Pharmaceutical, Inc., Rockville, MD

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 6.43 Quality of Life Improvement in Adolescent Schizophrenia and Pediatric Bipolar Disorder Following Treatment with Aripiprazole